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su
MaIntravascular imaging and physiology techniques and technologies are moving beyond the framework of research
to inform clinical decision making. Currently available technologies and techniques include fractional ﬂow reserve;
grayscale intravascular ultrasound (IVUS); IVUS radiofrequency tissue characterization; optical coherence tomography,
the light analogue of IVUS; and near-infrared spectroscopy that detects lipid within the vessel wall and that has recently
been combined with grayscale IVUS in a single catheter as the ﬁrst combined imaging device. These tools can be used to
answer questions that occur during daily practice, including: Is this stenosis signiﬁcant? Where is the culprit lesion? Is this
a vulnerable plaque? What is the likelihood of distal embolization or periprocedural myocardial infarction during stent
implantation? How do I optimize acute stent results? Why did thrombosis or restenosis occur in this stent? One of the
legacies of coronary angiography is to presume that one technique will answer all of these questions; however, that often
has been proved inaccurate in contemporary practice. (J Am Coll Cardiol 2014;64:207–22) © 2014 by the American
College of Cardiology FoundationM ore than 2 decades have passed since Drs.Nico Pijls and Bernard DeBruyne intro-duced fractional ﬂow reserve (FFR) as a
method of assessing coronary stenosis severity and
since Dr. Paul Yock invented grayscale intravascular
ultrasound (IVUS) that spawned second-generation
intravascular imaging techniques such as: 1) IVUS
radiofrequency tissue characterization, including vir-
tual histology (VH)-IVUS, integrated backscatter
IVUS, and iMap; 2) optical coherence tomography
(OCT), the light analogue of IVUS; and 3) near-
infrared spectroscopy that detects lipid within the
vessel wall and that has recently been combined
with grayscale IVUS in a single catheter as the ﬁrst
combined imaging device. These tools have moved
beyond the research setting. They are useful for
answering questions that occur during daily practice
including: Is this stenosis signiﬁcant? Where is
the culprit lesion? Is this a vulnerable plaque?
What is the likelihood of distal embolization orm the Cardiovascular Research Foundation, New York, New York. Dr. M
pport from Boston Scientiﬁc; and is a consultant to and receives research su
nuscript received September 30, 2013; revised manuscript received Januaperiprocedural myocardial infarction (MI) during
stent implantation? How do I optimize acute stent
results? Why did thrombosis or restenosis occur in
this stent?
The subspecialty of interventional cardiology is
data driven. Although correlations with histopa-
thology are important, the ultimate beneﬁt will be
determined if these techniques improve clinical
diagnosis, treatment, outcomes, and whether pa-
tients beneﬁt, irrespective of technical or histopath-
ological accuracy.
IS THIS STENOSIS SIGNIFICANT?
Three randomized trials (DEFER [Deferral Versus
Performance of PTCA in Patients Without Docu-
mented Ischemia], FAME [Fractional Flow Reserve
Versus Angiography for Multivessel Evaluation]-I,
and FAME-II) established FFR (the ratio of distal
to proximal pressure at maximum hyperemia) as theintz has received speakers’ bureau and fellowship
pport from Volcano Corporation and InfraReDx, Inc.
ry 2, 2014, accepted January 14, 2014.
ABBR EV I A T I ON S
AND ACRONYMS
DES = drug-eluting stent(s)
FFR = fractional ﬂow reserve
ISR = in-stent restenosis
IVUS = intravascular
ultrasound
LMCA = left main coronary
artery
MI = myocardial infarction
MLA = minimum lumen area
OCT = optical coherence
tomography
TCFA = thin-cap ﬁbroatheroma
VH = virtual histology
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208gold standard for assessing the signiﬁcance
of a non–left main coronary artery (LMCA)
lesion. DEFER showed it was safe to defer
percutaneous coronary intervention of le-
sions with an FFR >0.75 (1,2). The FAME-I
trial found that treating lesions with an
FFR >0.80 by using mostly ﬁrst-generation
drug-eluting stents (DES) was harmful,
whereas not treating such lesions was cost-
saving (3,4). The FAME-II trial found that
treating lesions with an FFR <0.80 with the
use of optimal medical therapy alone
was deleterious compared with optimal med-
ical therapy plus DES implantation (5). Al-
though initially more expensive, the
increased cost of “optimal medical therapyplus DES implantation” was decreased by one-half 1
year later (6).
Its predecessor, coronary ﬂow reserve (CFR),
measures the relative increase in coronary ﬂow ve-
locity during maximal hyperemia, reﬂecting both
epicardial stenoses and the microcirculation, and is
inﬂuenced by many factors affecting the microcircu-
lation, such as diabetes, ventricular hypertrophy, and
prior myocardial infarction. Unlike CFR, FFR is able to
measure the actual volume of blood ﬂow through a
stenotic coronary artery as a percentage of normal
hyperemic ﬂow, because at maximum hyperemia,
ﬂow into a myocardial territory is proportional to
pressure since the resistance is minimal and constant.
FFR is independent of pressure, heart rate, contrac-
tility, and the status of the microcirculation and takes
into account both antegrade and retrograde collat-
eral blood ﬂow, as well as the amount of viable
myocardium.
There has been a recent renewal of interest in
resting indices, such as iFR (instantaneous wave free
ratio) or a hybrid approach combining iFR and FFR.
However, the validity of these alternative physiologic
approaches will depend on the clinical outcomes of
randomized iFR vs. FFR trials, such as DEFINE-FLAIR
or SwedeHeart.
Many studies have attempted to identify invasive
imaging criteria that are equivalent to FFR or nonin-
vasive testing. Although the IVUS minimum lumen
area (MLA) in non-LMCA lesions is the parameter that
best correlates with physiology, reported IVUS MLA
cutoff thresholds range from 2.1 to 4.4 mm2 (Table 1)
(7–25) and are smaller in Asian patients than in
studies of Western populations, the “most common”
cutoff is approximately 3.0 mm2. Most IVUS studies
show a relatively high negative predictive value but a
low positive predictive value, indicating that using
IVUS to justify the need for percutaneousintervention is wrong approximately one-half of the
time. There have been no randomized IVUS trials
comparable to DEFER, FAME-I, or FAME-II or ran-
domized trials of IVUS deferral compared with FFR
deferral. However, a recent propensity-matched
study by de la Torre Hernandez et al. (26) suggests
that clinical outcomes are similar whether IVUS or
FFR is used to decide which lesions to stent or which
to leave alone, although a greater number of lesions
are stented with IVUS compared with FFR (72% vs.
51.2%; p < 0.0001).
Anatomic assessment of lesion severity is not
improved with OCT, although OCT-derived MLA
cutoffs are smaller than with IVUS (19,27–29). Some
studies have “corrected” for vessel size (12,13,16,17),
but none has factored in subtended viable
myocardium.
In a recent substudy from the PROSPECT
(Providing Regional Observations to Study Predictors
of Events in the Coronary Tree) Study, non-
ﬁbroatheromas were associated with very few events
at 3 years of follow-up, suggesting that tissue char-
acterization and plaque composition may be an
alternate method to predict lesion stability and defer
intervention (30).
LMCA LESIONS
Four angiographic studies (2 historic [31,32] and 2
contemporary [33,34]) indicated that agreement
among experts regarding the signiﬁcance of an
LMCA lesion can be as low as 30% (Fig. 1). There
have been 2 equivalent FFR and IVUS registry
studies in patients with intermediate LMCA lesions
in which an FFR >0.80 or an IVUS MLA >6.0 mm2
was used to defer revascularization, with
similar long-term results compared with patients
with an FFR <0.80 or an MLA <6.0 mm2 treated
with revascularization (33,35). A study by Jasti et al.
(36) in Western patients indicated that an IVUS
MLA <6 mm2 in the LMCA best correlated with an
FFR <0.80, while a study in Korean patients sug-
gested that 4.8 mm2 was the preferred IVUS MLA
cutoff (37), which is again consistent with the
smaller MLA cutoffs found in Asian patients
compared with Western patients.
Both IVUS and FFR have limitations in assessing
LMCA disease. Ideally, when clinically indicated,
IVUS should be performed from both the left anterior
descending and left circumﬂex coronary arteries to
deﬁne the MLA within the LMCA and to accurately
assess disease at the left anterior descending and left
circumﬂex ostia (38,39). Patients with LMCA disease
have not typically been included in the many FFR
TABLE 1 IVUS MLA Cutoff Points Associated With Ischemia
Ref. # (7) (8) (9) (10) (11) (12) (13,14) (15) (16,17) (18) (19) (20) (21) (22) (23) (24) (25)
N 112 70 51 53 14 94 236 170 205 267 47 304 544 169 LAD 323 206 LAD 700 LAD
Comparison technique used
to assess ischemia
CFR SPECT FFR FFR FFR FFR FFR SPECT FFR FFR FFR FFR FFR FFR FFR FFR FFR
% abnormal 40 65 49 23 50 40 21 26 26 33 46 28 31 59 54 44 38
IVUS
Mean MLA (mm2) 4.4 4.3 3.9 3.9 3.5 2.3 2.6 2.1 3.5 3.0 2.6 3.5 3.3 3.0 2.9 3.1 2.5
MLA cut-off (mm2) 4.0 4.0 3.0 4.0 N/A 2.0 2.4 2.1 3.1 2.8 2.4 3.0 2.9 3.0 3.0 3.2 prox
2.5 mid
2.5
Other IVUS determinants
of ischemia
LL MLA/LL PB
LL
PB
LAD
PB Vessel size Prox vs.
Mid
LAD
PB LAD
EEM
PB
LL
PB
LL
LAD
LL
Prox vs. Mid
PB
LL
PB
CFR ¼ coronary ﬂow reserve; EEM ¼ external elastic membrane; FFR ¼ fractional ﬂow reserve; IVUS ¼ intravascular ultrasound; LAD ¼ left anterior descending; LL ¼ lesion length; Mid ¼ middle;
MLA ¼ minimum lumen area; PB ¼ plaque burden; Prox ¼ proximal; SPECT ¼ single-photon emission computed tomography.
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209validation studies, and FFR may have limitations in
the setting of a signiﬁcant concomitant LAD stenosis
(40,41).
WHERE IS THE CULPRIT LESION?
In patients with acute coronary syndrome, plaque
rupture occurs in 60% to 65% of cases, plaque erosion0 1.0
FIGURE 1 Artifactual Ostial LMCA “Lesion”
This 47-year-old male patient was admitted to a coronary care unit becau
by bypass surgery (left internal mammary artery to the left anterior des
ostial left main stenosis similar to the one shown by the white arrow in
recurrent pain. He was readmitted to the coronary care unit, underwent
mammary artery and saphenous vein grafts), and had repeat bypass sur
descending and left circumﬂex arteries. He again did well for about 1 mon
referred for an intravascular ultrasound (IVUS) study of the ostial left m
main disease or lumen compromise. There was at most mild intimal thicke
catheter had been retracted and was out of view. Adapted with permissiin 30% to 35%, and a calciﬁed nodule in 5%.
The ﬁnal common pathway is thrombus formation
(42). Sometimes, the culprit lesion is evident clini-
cally, but as seen in the VANQWISH (Veterans Af-
fairs Non-Q-Wave Infarction Strategies in-Hospital)
trial, nearly 50% of these patients either have
no identiﬁable culprit or have multiple potential
culprits (43).4.0mm
se of chest pain, initially underwent diagnostic angiography followed
cending and saphenous vein graft to the left circumﬂex artery) for an
this angiogram. He did well for approximately 1 month, developed
repeat angiography (which showed closure of both the internal
gery, this time using saphenous vein grafts to both the left anterior
th before developing recurrent chest pain. At this time, the patient was
ain stenosis. IVUS of the ostial stenosis (white arrow) showed no left
ning (a). Note the shadowing caused by the aortic wall (b). The guiding
on of CRF Press from Intracoronary Ultrasound by Gary S. Mintz.
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FIGURE 2 Identiﬁcation of a Culprit Lesion
This middle-aged man presented with an acute coronary syndrome. (A) Angiography showed 2 potential culprit lesions: 1 in the left anterior descending (a)
and 1 in the left circumﬂex (b) arteries. (B) Optical coherence tomography (OCT) imaging of the left anterior descending showed plaque rupture (c), but no
thrombus formation. (C) OCT imaging of the left circumﬂex showed thrombus (d), identifying it as the culprit lesion, and presumed erosion. Illustration
courtesy of Takashi Kubo, MD, and Takashi Akasa, MD, of Wakayama Medical University, Wakayama, Japan.
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210Previous studies have shown that positive remod-
eling is more common in culprit lesions of patients
presenting with acute coronary syndrome and is seen
in association with plaque rupture, yellow plaque
color, and thrombus formation. Conversely, negativeremodeling is more common in target lesions of
patients presenting with stable symptoms (44–47).
IVUS detects plaque ruptures in approximately one-
half of ST-segment elevation MI culprit lesions
(48–50). However, the superior resolution and the
Proximal Distal
A
B DC E F
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FIGURE 3 Spontaneous Coronary Artery Dissection
This post-partum woman was admitted due to chest pain. (A) Coronary angiography showed a severe stenosis from proximal to distal left
anterior descending artery (double-headed black arrow). Corresponding intravascular ultrasound imaging (B to F, with duplicated and an-
notated images B’ to F’) showed a spontaneous dissection (double-headed white arrow), intramural hematoma (a) and contrast retention (b).
The gray areas on the annotated frames (B’ to F’) indicated the true lumen, the white areas indicated the false lumen, and the black area
indicated contrast retention. The nondissected image slice (B) showed a nonatherosclerotic coronary artery that was typical for spontaneous
coronary artery dissection.
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211obligatory ﬂushing with OCT sharply outline the
plaque rupture cavity and residual ﬁbrous cap frag-
ment to optimize ruptured plaque identiﬁcation (48);
OCT can detect erosions (although there is some
disagreement regarding the deﬁnition [48,51–53]);
and OCT can identify and differentiate between red
and white thrombus (54). However, red thrombus,
which is almost universal in these patients, can
shadow and obscure underlying plaque morphology
(Fig. 2). Recent near-infrared spectroscopy data indi-
cate that a maximum lipid core burden index >400
within a 4-mm segment is a signature of plaques
causing an ST-segment elevation MI (55).
Other unusual culprit lesion morphologies that can
be detected by using both IVUS and OCT include
calciﬁc nodules (53,56) and spontaneous coronary
artery dissections (Fig. 3) (57,58).IS THIS A VULNERABLE PLAQUE?
The precursor of the ruptured, thrombotic plaque
is the thin-cap ﬁbroatheroma (TCFA), the most com-
mon type of vulnerable plaque (42). Although 1 early,
small, grayscale IVUS study suggested that a large
eccentric plaque containing a shallow echolucent
zone is at increased risk for instability (59), to date
only VH-IVUS has been shown to predict future
nonculprit events. In the PROSPECT study, predictors
of nonculprit events at 3 years were a VH-TCFA, an
IVUS MLA <4.0 mm2, and an IVUS plaque burden
>70% (60). These ﬁndings, especially the importance
of a large plaque burden, were supported by the
VIVA (VH-IVUS in Vulnerable Atherosclerosis) and
ATHEROREMO-IVUS (European Collaborative Project
on Inﬂammation and Vascular Wall Remodeling
A B
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FIGURE 4 Extensive Attenuated Plaque in the LMCA
(A) Coronary angiography showed intermediate stenosis in the middle of the left main coronary artery (LMCA). (B to D) Cross-sectional images
showed extensive attenuated plaque (a) over 270 of the arterial circumference (B) that was superﬁcial, beginning near the lumen (dotted
white line). The longitudinal reconstructed image (B) indicated the length of the attenuated plaque (double-headed arrow, b) in relationship to
the length of the LMCA (double-headed arrow, c). (C) The minimum lumen area measured by intravascular ultrasound was 4.4 mm2. During
stent implantation, the patient developed prolonged no-reﬂow.
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212in Atherosclerosis–Intravascular Ultrasound) studies
(61,62).
Although VH-IVUS can only infer the presence of
a TCFA by the presence of a necrotic core abutting
the lumen, OCT is able to identify many features of a
TCFA, including ﬁbrous cap thickness <65 mm, mac-
rophages in the ﬁbrous cap, and an underlying lipid
core (51). However, only 1 small OCT study has found
that lesions with rapid progression (angiographic
lumen loss >0.4 mm within 7 months) have an
increased frequency of intimal laceration, micro-
vessels (which may be a source of blood extravasation
and intraplaque hemorrhage), lipid pools, TCFAs,
macrophages, and intraluminal thrombi (63).
IVUS substudies of the PROSPECT study have
highlighted the paradox between plaque ruptures or
calciﬁed nodules that cause acute coronary syndrome
events versus the benign nature of secondary, non-
culprit plaque ruptures or calciﬁed nodules that
are detected incidentally (64,65). Although positive
remodeling was not an independent predictor of
events in the PROSPECT, VIVA, or ATHEREMO-IVUS
studies, a substudy from the PROSPECT study found
that it is not just positive remodeling, but also the
extremes of positive and negative remodeling that
predicted events (66).The appropriateness of using routine invasive
imaging to screen for vulnerable plaques as part of
primary or secondary prevention is the subject of
debate and depends on the prevalence of vulnerable
plaques, as well as how often and how rapidly they
develop spontaneously, remain unstable, or stabilize
(67,68); the impact of contemporary medical therapy
on clinical events; and complications associated with
routine 3-vessel invasive imaging (60). PROSPECT,
VIVA, and ATHEROREMO-IVUS studies demon-
strated that contemporary medical therapy mostly
impacted revascularization and not hard events of
death or MI (60–62). Currently, we cannot predict
which plaques carry a risk of complications high
enough to warrant prophylactic therapy, although a
randomized substudy within the PROSPECT-II study
will attempt to address this issue.
WHAT IS THE LIKELIHOOD OF DISTAL
EMBOLIZATION OR PERIPROCEDURAL MI
DURING STENT IMPLANTATION?
Predictors of myonecrosis during stent implantation
are a large, grayscale IVUS attenuated plaque
(“shadowing” in the absence of calciﬁcation), espe-
cially when shadowing begins closer to the lumen
FIGURE 5 Very Late Stent Thrombosis With Aneurysm and Stent Fracture
The left anterior descending artery has been treated using 2 Cypher stents (Cordis Corporation, Miami Lakes, Florida) 1.5 years ago. (A and B)
Coronary angiogram shows stent thrombosis (white arrow in A) with stent fracture (white arrow in B). (C to E) Intravascular ultrasound
imaging reveals aneurysm formation (a), that was better seen in the longitudinal reconstruction (b in F), and (E) absence of stent struts
conﬁrming stent fracture. The external elastic membrane area in the proximal reference (C) measures 14.1 mm2, and the external elastic
membrane area at the site of the aneurysm (D) measures 31.4 mm2.
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213than to the adventitia (69–73) (Fig. 4); a large VH-IVUS
necrotic core, VH-TCFA (74), or similar ﬁndings using
integrated backscatter IVUS (75,76) or iMap (77); a
large amount of OCT lipid or an OCT-TCFA (78–83); a
large lipid-rich plaque detected by using near-
infrared spectroscopy (84–86); and the presence of
plaque rupture, whether detected by IVUS or OCT
(79,87–90). The common denominator is the presence
of a TCFA, with or without plaque rupture, that is
responsible both for the imaging ﬁndings and for
periprocedural MI during stent implantation (91–94).
Conversely, the absence of these ﬁndings indicates
a low probability of a periprocedural MI.HOW DO I OPTIMIZE ACUTE STENT RESULTS?
In both bare-metal stents and DES, the IVUS pre-
dictors of early stent thrombosis or in-stent reste-
nosis (ISR) are underexpanded stent (Fig. 5) (95–112)
and inﬂow/outﬂow track disease (e.g., dissections,
signiﬁcant plaque burden, edge stenosis) (99,104,105,
107,108,113–116), but not acute stent malapposition
(108,110,117–119) as long as the stent is well expanded.
Underexpansion refers to the size of the stent,
whereas malapposition refers to the contact of
the stent with the vessel wall. The 2 terms and
concepts are not interchangeable, and the term
Proximal
Calcium
Calcium
Calcium
Calcium
Proximal reference MSA site Distal reference
Proximal reference MSA site Distal reference
6.0 mm26.0 mm2
3.1 mm2 6.0 mm26.0 mm2
6.0 mm2
Distal
Proximal Distal
Stent Malapposition
Stent Underexpansion
* *
* *
FIGURE 6 Malapposition Versus Underexpansion
Acute stent malapposition and underexpansion can co-exist; however, as shown in this illustration, they can occur independently and should
not be confused. Malapposition refers to lack of contact of stent struts with the vessel wall. As shown in the top schematic, malapposition (*)
occurs at the junction of calciﬁed and noncalciﬁed plaque and in localized areas of reference segment ectasia at the stent edges. However, the
stent is fully (albeit not symmetrically) expanded since the MSA of 6.0 mm2 matches the proximal and distal reference segment lumen areas.
Conversely and as shown on the bottom schematic, underexpansion refers to an MSA that is substantially smaller than the proximal and distal
reference segment lumen areas, in this case caused by extensive, circumferential calcium. MSA ¼ minimum stent area.
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214“underdeployment” is imprecise and unclear (Fig. 6).
Although bigger is better regarding stent expansion
and less is more with respect to stent edge plaque
burden, acceptable procedural endpoints are a mini-
mum stent area (98,101,104,106,109,111,112) and
stent-edge plaque burden (113,115,116) that maximize
the probability of long-term stent patency while
minimizing the risk of stent failure (Table 2).
Four meta-analyses of the randomized IVUS versus
angiographic-guided bare-metal stent implantationtrials showed that IVUS guidance reduced reste-
nosis, repeat revascularization, and major adverse
cardiac events but not death or MI (120–123). Four
meta-analyses of IVUS versus angiographic-guided
DES studies (the most recent of which involving 3
randomized trials and 14 observational studies with
26,503 patients) found that IVUS guidance reduced
stent thrombosis (124–127), MI (125–127), repeat re-
vascularization (126,127), and mortality (124–127)
despite using more stents and/or longer stents in
TABLE 2 IVUS Studies and Cutpoints for Acute MSA, Stent Length, and/or Edge Plaque Burden That Were Predictors of Events
at Follow-Up After BMS or DES Implantation
Ref. # N Follow-Up Stent Acute Endpoint MSA Location Cutoff Sensitivity Speciﬁcity
(98) 543 TLR BMS MSA 6.5 mm2 PPV ¼ 17%, NPV ¼ 94%
(101) 60 IVUS MLA <4 mm2 BMS MSA 6.5 mm2 63% 78%
72 SES 5.0 mm2 76% 83%
(104) 543 Angiographic in-stent restenosis SES MSA 5.5 mm2 67% 67%
Stent length 40 mm 81% 78%
(106) 482 Angiographic in-stent restenosis BMS MSA 6.4 mm2 c statistic ¼ 0.64
1,098 PES 5.7 mm2 c statistic ¼ 0.64
(109) 403 Angiographic in-stent restenosis SES MSA LM 8.2 mm2 80% 81%
POC 7.2 mm2 100% 78%
LAD ostium 6.3 mm2 73% 85%
LCX ostium 5.0 mm2 78% 78%
(111) 541 Angiographic in-stent restenosis SES MSA 5.5 mm2 72% 66%
229 EES 5.4 mm2 60% 60%
220 ZES 5.3 mm2 57% 62%
(112) 106 IVUS MLA <4 mm2 DES MSA Main vessel 6.1 mm2 PPV ¼ 91%
Side branch 4.8 mm2 PPV ¼ 70%
(115) 255 Angiographic edge restenosis BMS Edge plaque burden 48% c statistic ¼ 0.70
276 PES 47% c statistic ¼ 0.69
(116) 433 Angiographic edge restenosis E-ZES Edge plaque burden 56.3% 67% 86%
422 R-ZES 57.3% 80% 87%
813 EES 54.2% 86% 80%
BMS ¼ bare-metal stent(s); DES ¼ drug-eluting stent(s); EES ¼ everolimus-eluting stent(s); IVUS ¼ intravascular ultrasound; LCX ¼ left circumﬂex; LM ¼ left main; MSA ¼
minimum stent area; NPV ¼ negative predictive value; PES ¼ paclitaxel-eluting stent(s); POC ¼ polygon of conﬂuence; PPV ¼ positive predictive value; SES ¼ sirolimus-eluting
stent(s); TLR ¼ target lesion revascularization; ZES ¼ zotarolimus-eluting stent(s).
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215IVUS-guided patients. A propensity score–matched
analysis was possible in 9 studies (124,126), and
there was no evidence of heterogeneity or publication
bias. IVUS guidance was associated with a larger
post-procedure angiographic minimum lumen diam-
eter with no evidence of increased periprocedural
MI (127). Two studies questioned the value of IVUS
guidance in MI patients undergoing primary per-
cutaneous intervention (128,129), but the ADAPT-DES
(Assessment of Dual Antiplatelet Therapy With Drug-
Eluting Stents) study suggested the opposite: thatTABLE 3 Causes of Stent Failure (Thrombosis or Restenosis) Detecte
Bare-Metal Stents
Stent Thrombosis Resten
<30 days >1 yr <5 ys
Procedure-related complications
including underexpansion, edge plaque
burden or dissection, geographic miss
X X
Intimal hyperplasia X
Neoatherosclerosis X
Late malapposition or aneurysm formation
Stent fracture X X
Uncovered stent strutsIVUS guidance had its greatest impact in MI patients
(130). Most recently, a study reporting patient-level
data from 4 Spanish registries showed that IVUS
guidance reduced cardiac death, MI, and repeat
revascularization in patients undergoing DES im-
plantation for unprotected LMCA disease (131).
To date, there has been only 1 study of OCT versus
angiographic-guided DES implantation, with relative
beneﬁts found similar to the IVUS meta-analyses
(120–123). These ﬁndings suggest that it might not
be the individual imaging technique per se that isd By Using Intravascular Imaging
Drug-Eluting Stents
osis Stent Thrombosis Restenosis
>5 ys <30 days 30 days–1 yr >1 yr <18 months >18 months
X X
X
X X X
X
X X X
X X
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216beneﬁcial but the increased information provided
compared with angiography alone (132). Advocates
of OCT have cited superior resolution, enhanced im-
aging during ﬂushing, ease of image interpretation,
and detection of dissections, tissue protrusion, and
malapposition not seen on IVUS (133–135). However,
unlike IVUS, there are no established concepts
regarding stent sizing by using OCT, and there are
little data on OCT criteria for optimal stent implan-
tation or predictors of adverse events. For example,
there is no agreement whether an OCT-measured
minimum stent area is larger, smaller, or the same
as IVUS (133–136). Enhanced OCT detection of stentCENTRAL ILLUSTRATION Recommended Intravascular Imaging an
Current Literatureedge dissections, tissue prolapse, thrombus, or stent-
vessel wall malapposition is not associated with
predicting adverse events (137–140). One small, ran-
domized, blinded study comparing IVUS- versus
OCT-guided DES implantation found that, because of
its limited penetration, less aggressive OCT stent
sizing is associated with more stent underexpansion
and a larger reference segment plaque burden
compared with IVUS (136).
Although FFR has a limited role in stent optimi-
zation, it is probably the best technique to determine
whether a jailed side branch is compromised after
provisional bifurcation stenting (141–145). Most of thed Physiology Techniques in Coronary Heart Disease Based on the
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217time, the angiographic appearance of side branch ostial
lumen compromise is an artifact, and FFR is >0.80
because lumen compromise is due to carina shift
that is eccentric and focal and not due to plaque shift.
WHY DID THROMBOSIS OR RESTENOSIS
OCCUR IN THIS STENT?
While most causes of stent thrombosis and ISR
(Table 3) have been elucidated with IVUS, they can
also be detected with OCT. The emergence of neo-
atherosclerosis as an important cause of late stent
failure (146–156), and observations regarding the
relationship between lack of stent strut tissue
coverage and late/very late stent thrombosis
(157,158), neither of which can be identiﬁed by using
IVUS (148), indicate that OCT may be the imaging
technology of choice in this clinical setting.
OCT studies have shown that neoatherosclerosis
occurs earlier after DES than bare-metal stents, occurs
with greater frequency with many types of DES
versus bare-metal stents, can present as either ISR or
very late stent thrombosis, and may be responsible
for the majority of very late stent thrombosis; it is
associated with greater clinical instability at the
time of presentation (ACS in ISR and STEMI in very
late stent thrombosis) and periprocedural MI at
the time of treatment of ISR or stent thrombosis
(146–156). However, it should be noted that OCT
ﬁndings in stent thrombosis may depend on whether
aspiration thrombectomy is performed before (154)
or after (157) OCT imaging, because aspiration will
remove not only thrombus but also fragments ofatherosclerotic plaques such as foamy macrophages,
cholesterol crystals, and a thin ﬁbrous cap (159).
Other than neoatherosclerosis, the clinical impact of
OCT patterns on neointimal tissue (i.e., heteroge-
neous vs. homogeneous vs. layered vs. peri-strut low-
intensity areas [160–169]) are not clear.
SUMMARY AND BARRIERS TO
IMPLEMENTATION
There are 3 main barriers to implementing an
intravascular imaging and physiology program: cost,
expertise, and convincing interventional cardiolo-
gists of the limitations of relying on coronary angi-
ography alone. In some countries, the cost of these
techniques can dwarf that of the other materials
used during percutaneous intervention. Education
is problematic; interpretation is not intuitive, not
even with OCT (170); and requires an understanding
of artifacts, limitations, and confounders, like all
medical imaging techniques. One of the legacies of
coronary angiography is to presume that one tech-
nique will answer all of these questions; however,
that often has been proved inaccurate in contem-
porary practice. Although there may be few ran-
domized trials, the utility of these techniques to
answer routine clinical questions is undeniable
(Central Illustration).
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